SVA US EQUITY Health Care Health Care CIK: 1084201

SINOVAC BIOTECH LTD (SVA) Quant Factor Diagnostic & Fair Value Model

SINOVAC BIOTECH LTD (Ticker: SVA) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

$6.47
0.00% Latest Close (2025-09-05)
Market Cap: $1.10B
P/E Ratio: -
Momentum Strength 3M / 12M
-13.62%
1M: +0.15% 12M: 0.00%
Quality (ROE) Point-in-Time
-
Trailing Return on Equity
Technical Trend RSI 14
42.0
SMA50: $6.63 SMA200: $6.97
Valuation Multiplier Trailing
-
Pre-Profit / Negative TTM
📊 Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM

SVA has negative or near-zero trailing GAAP earnings over the trailing twelve months.

⚡ Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线整理 (MA20/50) Piotroski F-Score: 1/9 (Under Pressure or Early Stage Growth)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 1084201 · 10-K 年报 / 10-Q 季报
Form Period End Filing Timestamp (Point-in-Time) Revenue Net Income Operating CF EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1084201

💡 Methodology & Frequently Asked Questions

Key reference details regarding SINOVAC BIOTECH LTD (SVA) valuation multiples, momentum factors, and point-in-time filing conventions.

How should SVA's current valuation multiple be interpreted? ↓
SVA trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are SVA's key momentum and technical factor indicators? ↓
As of the latest close, SVA shows a 1-month return of +0.15%, 3-month return of -13.62%, and 12-month return of 0.00%, with a 14-day RSI of 42.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for SVA? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can SVA be incorporated into systematic factor models? ↓
SVA can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.

Related Peers & Valuation Comparison in Health Care

Dense Internal Network Mesh